( b ) to occupy central 5-ht2 receptors in vivo ( measured by the binding of [ 3h ] spiperone in the frontal cortex ) and ( c ) to affect the concentrations of d-fenfluramine and its active metabolite , d-norfenfluramine in brain .
C0086045
concentrations
C0006104
brain